bridging science, policy and advocacy
precision medicine
precision medicine and biomarkers present an incredible opportunity to revolutionize health care. it has the potential to change the way we think about, identify and manage cancer care. the impact on both clinical research and patient care will grow as our understanding and technologies improve transforming the delivery of cancer care to benefit both patients and cancer care systems.
managing innovation in oncology
capacity building
the cancer collaborative considers advocacy an important tool in improving cancer care at provincial, national and global levels and patient advocates who are well informed and who have a thorough understanding of the clinical and political landscape can better identify, shape and influence policy and develop effective advocacy strategies and communication with decision makers. strengthening their capacity to address québec specific challenges and opportunities, and to better understand, respond and engage within the pan-canadian environment to proactively engage in an effective and efficient manner.
How Wearable Technologies are Creating New Clinical Trial Endpoints
this is a guest article and does not necessarily reflect the views and values of the cancer collaborative. the original article was created by Impetus Digital and can be found here. Wearable technologies are gaining a lot of interest as a means of data collection in...
what are biomarkers
understanding cancer - cancer is a disease that is characterized by abnormal cell process involving uncontrolled cell growth and proliferation that alters normal cell behaviour. the genetic alterations within the cancer cells will be manifested by the release of...
improving access to innovative therapies
here's how biologics have become an important part in the cancer landscape, providing better outcomes for some patients . because they are made from living organisms biologics can not be exactly copied [generics]. the complex manufacturing process of biologics results...
How Wearable Technologies are Creating New Clinical Trial Endpoints
this is a guest article and does not necessarily reflect the views and values of the cancer collaborative. the original article was created by Impetus Digital and can be found here. Wearable technologies are gaining a lot of interest as a means of data collection in...
what are biomarkers
understanding cancer - cancer is a disease that is characterized by abnormal cell process involving uncontrolled cell growth and proliferation that alters normal cell behaviour. the genetic alterations within the cancer cells will be manifested by the release of...
improving access to innovative therapies
here's how biologics have become an important part in the cancer landscape, providing better outcomes for some patients . because they are made from living organisms biologics can not be exactly copied [generics]. the complex manufacturing process of biologics results...
precision medicine awareness month launches in canada
throughout the month of november, the cancer collaborative in collaboration with the european cancer patients coalition [ECPC] will highlight the growing role that precision medicine plays in oncology through the CRACKING THE CANCER CODE campaign. the premise of...
our REPORTs
If you haven’t already done so - don’t forget to register for @LymphomaCanada Annual Patient Conference taking place 14.10.2021 register here https://www.lymphoma.ca/news-events/national-conference-2021/
we work hard in the background to make sure all canadians have accessing not only to CAR-T but all the therapies they need and sometimes we get recognized for the work we do. thank you https://www.healthinsight.ca/advocacy/car-t-cell-immunotherapy-plays-important-role-in-hard-to-treat-lymphoma/?_thumbnail_id=21578